Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Polycystic Ovary Syndrome 1Myelodysplastic-Myeloproliferative Diseases 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Insulin Resistance 1Inflammation 1Hyperandrogenism 1Congenital Abnormalities 1Anovulation 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Metformin 8Progesterone 6Spironolactone 4drospirenone and ethinyl estradiol combination 3Inositol 3Ethinyl Estradiol 3salicylsalicylic acid 2Sugars 2Folic Acid 2Flutamide 2Estradiol 2Cyproterone Acetate 2Clomiphene 2maltodextrin 1licogliflozin 1bicalutamide 1Yoga 1Topiramate 1Thioctic Acid 1Sodium Salicylate 1Phlebotomy 1Ovidrel 1Magnesium 1Lactalbumin 1Inulin 1Glycoprotein Hormones, alpha Subunit 1Estrogens 1Doxycycline 1Dexamethasone 1Cyproterone acetate, ethinyl estradiol drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hyperandrogenism × Sodium Salicylate × Clear all
NCT03229408 2025-06-10

TIN-PCOS-AOD

University of Illinois at Chicago

Phase 2 Completed
60 enrolled 28 charts

Anovulation, Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡